Maya Fayfman
Overview
Dr. Maya Fayfman received her medical training at Boston University School of Medicine, her Internal Medicine residency at Tufts Medical Center and completed her fellowship training in Endocrinology and Metabolism at Emory University.
Dr. Fayfman is now part of the Diabetes Research Group within the Emory University School of Medicine and Grady Hospital. Her research interests include inpatient management of diabetes and hyperglycemia and hospital outcomes in racial minorities.
Academic Appointment
- Assistant Professor of Medicine, Department of Medicine, Division of Endocrinology, Metabolism and Lipids, Emory University School of Medicine
Education
Degrees
- MD from Boston University
Research
Publications
-
Intelligent Care Management for Diabetic Foot Ulcers: A Scoping Review of Computer Vision and Machine Learning Techniques and Applications.
J Diabetes Sci Technol Volume: 19 Page(s): 820 - 829
05/01/2025 Authors: Baseman C; Fayfman M; Schechter MC; Ostadabbas S; Santamarina G; Ploetz T; Arriaga RI -
Single-Cell Analysis of Debrided Diabetic Foot Ulcers Reveals Dysregulated Wound Healing Environment in Non-Hispanic Black Patients.
J Invest Dermatol Volume: 145 Page(s): 678 - 690
03/01/2025 Authors: Choi D; Bakhtiari M; Pilcher W; Huang C; Thomas BE; Mumme H; Blanco G; Rajani R; Schechter MC; Fayfman M -
High Prescription Rate of Medications With Rifampin Drug-drug Interactions in Patients With Diabetic Foot Osteomyelitis: Should Rifabutin Be Included in Clinical Trials for Adjunctive Therapy?
Open Forum Infect Dis Volume: 11 Page(s): ofae582
11/01/2024 Authors: Mallarino-Haeger C; Watson A; Mahgoub U; Francis L; Heydari M; Choudhary M; Garcia-Toca M; Patel M; Kempker RR; Fayfman M -
Feasibility of Multiparametric Perfusion Assessment in Diabetic Foot Ulcer Using Intravoxel Incoherent Motion and Blood Oxygenation-Level Dependent MRI.
J Magn Reson Imaging Volume: 59 Page(s): 1555 - 1566
05/01/2024 Authors: Edwards SJ; Yao J; Schechter MC; Fayfman M; Santamarina G; Feiweier T; Blanco G; Alvarez J; Risk BB; Rajani R -
Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes.
Diabetes Care Volume: 47 Page(s): 267 - 271
02/01/2024 Authors: Kaminski CY; Galindo RJ; Navarrete JE; Zabala Z; Moazzami B; Gerges A; McCoy RG; Fayfman M; Vellanki P; Idrees T -
Microbiome differences related to metformin intolerance among Black individuals with diabetes, a pilot cross-sectional study.
Metabol Open Volume: 20 Page(s): 100256
12/01/2023 Authors: Fayfman M; Gewirtz AT; Delaroque C; Blanco G; Gibanica S; Srinivasan S; Chassaing B -
A Randomized Controlled Trial Comparing the Efficacy and Safety of IDegLira Versus Basal-Bolus in Patients With Poorly Controlled Type 2 Diabetes and Very High HbA1c 9-15%: DUAL HIGH Trial.
Diabetes Care Volume: 46 Page(s): 1640 - 1645
09/01/2023 Authors: Galindo RJ; Moazzami B; Scioscia MF; Zambrano C; Albury BS; Saling J; Vellanki P; Pasquel FJ; Davis GM; Fayfman M -
Executive Summary: Evaluation and Management of Diabetes-related Foot Infections.
Clin Infect Dis Volume: 77 Page(s): 335 - 337
08/14/2023 Authors: Cortes-Penfield NW; Armstrong DG; Brennan MB; Fayfman M; Ryder JH; Tan T-W; Schechter MC -
Evaluation and Management of Diabetes-related Foot Infections.
Clin Infect Dis Volume: 77 Page(s): e1 - e13
08/14/2023 Authors: Cortes-Penfield NW; Armstrong DG; Brennan MB; Fayfman M; Ryder JH; Tan T-W; Schechter MC -
Diabetes Technology Meeting 2022.
J Diabetes Sci Technol Volume: 17 Page(s): 1085 - 1120
07/01/2023 Authors: Huang J; Yeung AM; DuBord AY; Wolpert H; Jacobs PG; Lee W-A; Drincic A; Spanakis EK; Sherr JL; Prahalad P